FDA grants market clearance for new Kleiner spinal fusion device

The FDA cleared Incline Village, Nev.-based Kleiner Device Labs’ new KG2 Surge flow-through interbody system for market use, the company said Sept. 22.

Advertisement

The system’s interbody device is 3D-printed titanium featuring a diamond lattice porous structure designed to facilitate bone ingrowth. It will initially be available in footprints of 9×24 millimeters, 11×28 millimeters and 11×32 millimeters, with heights of 7 to 14 millimeters and lordosis of 0 and 6 degrees.

The system is designed to maximize bone graft delivery volume, distribute graft bilaterally into the intervertebral disc space, and streamline the implant, delivery, positioning and grafting process for transforaminal lumbar interbody fusion and posterior lumbar interbody fusion procedures, the company said.

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Register to Attend Webinar

160 ambulatory leaders just ranked the EHR as the single system most overdue for AI reinvention

Tuesday, August 11
12:00 PM - 1:00 PM CDT

Presenter: Gautam Shah, MBA, FACHDM, NextGen Healthcare

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.